151 companies
Madrigal Pharmaceuticals
Market Cap: US$10.8b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$476.89
7D
5.3%
1Y
68.9%
Travere Therapeutics
Market Cap: US$4.4b
A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.
TVTX
US$48.57
7D
13.1%
1Y
221.0%
Infinity Natural Resources
Market Cap: US$862.8m
Engages in the acquisition, exploration, and development of properties to produce crude oil, natural gas, and natural gas liquids in the United States.
INR
US$13.59
7D
3.0%
1Y
-20.9%
Lumentum Holdings
Market Cap: US$69.7b
Manufactures and sells optical and photonic products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.
LITE
US$821.76
7D
-20.2%
1Y
902.6%
Zevra Therapeutics
Market Cap: US$714.7m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$13.66
7D
25.6%
1Y
47.2%
Syndax Pharmaceuticals
Market Cap: US$1.5b
A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.
SNDX
US$17.69
7D
-3.8%
1Y
57.4%
PicS
Market Cap: US$1.2b
Operates as a digital financial services company that provides digital wallet and application for individuals and businesses in Brazil.
PICS
US$9.79
7D
-12.4%
1Y
n/a
Broadcom
Market Cap: US$1.9t
Designs, develops, and supplies various semiconductor devices and infrastructure software solutions internationally.
AVGO
US$392.16
7D
-18.6%
1Y
60.3%
AppLovin
Market Cap: US$189.4b
Provides end-to-end artificial intelligence-powered advertising solutions for businesses in the United States and internationally.
APP
US$520.84
7D
-14.0%
1Y
35.8%
AnaptysBio
Market Cap: US$1.5b
A clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States.
ANAB
US$51.63
7D
0.7%
1Y
115.4%
Ardelyx
Market Cap: US$1.4b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$5.60
7D
1.4%
1Y
49.7%
National Energy Services Reunited
Market Cap: US$2.5b
Provides oilfield services in the Middle East and North Africa.
NESR
US$24.06
7D
-2.7%
1Y
295.7%
WaterBridge Infrastructure
Market Cap: US$3.7b
WaterBridge Infrastructure LLC, water infrastructure company, provides water management solutions through integrated pipeline and water handling networks in the United States.
WBI
US$29.34
7D
-2.1%
1Y
n/a
AGI
Market Cap: US$1.0b
Provides technology-powered specialized financial services in Brazil.
AGBK
US$6.61
7D
-5.6%
1Y
n/a
Oracle
Market Cap: US$609.2b
Offers products and services that address enterprise information technology environments worldwide.
ORCL
US$205.81
7D
-15.9%
1Y
16.0%
Alignment Healthcare
Market Cap: US$3.2b
Operates a consumer-centric healthcare platform for seniors in the United States.
ALHC
US$19.20
7D
40.8%
1Y
31.1%
FTAI Aviation
Market Cap: US$23.6b
Owns, acquires, and sells aviation equipment for the transportation of goods and people worldwide.
FTAI
US$233.75
7D
-4.9%
1Y
93.0%
Abeona Therapeutics
Market Cap: US$306.6m
A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.
ABEO
US$5.45
7D
-4.2%
1Y
-15.6%
Columbus McKinnon
Market Cap: US$355.2m
Designs, manufactures, and markets motion solutions for moving, lifting, positioning, and securing materials.
CMCO
US$12.71
7D
-19.7%
1Y
-22.2%
Pelthos Therapeutics
Market Cap: US$91.4m
A bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.
PTHS
US$26.90
7D
3.5%
1Y
108.4%
UroGen Pharma
Market Cap: US$1.3b
A biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers.
URGN
US$28.18
7D
6.2%
1Y
299.7%
ARS Pharmaceuticals
Market Cap: US$892.7m
A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally.
SPRY
US$9.41
7D
5.7%
1Y
-35.9%
Capricor Therapeutics
Market Cap: US$1.5b
A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.
CAPR
US$26.01
7D
-4.9%
1Y
87.3%
Compass
Market Cap: US$5.7b
Provides an end-to-end technology platform for residential real estate in the United States.
COMP
US$8.17
7D
-5.3%
1Y
28.9%
AVITA Medical
Market Cap: US$128.0m
Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
RCEL
US$4.12
7D
-1.7%
1Y
-31.2%
Pagaya Technologies
Market Cap: US$1.3b
A product-focused technology company, deploys data science and proprietary artificial intelligence-powered technology for financial services, their customers, and institutional or sophisticated investors in the United States, Israel, and the Cayman Islands.
PGY
US$14.80
7D
-3.2%
1Y
-17.7%
EHang Holdings
Market Cap: US$660.6m
Operates as an urban air mobility (UAM) technology platform company in the People’s Republic of China, East Asia, West Asia, North America, South America, West Africa, and Europe.
EH
US$6.68
7D
-34.6%
1Y
-60.7%
Luckin Coffee
Market Cap: US$9.9b
Offers retail services of freshly brewed drinks, and pre-made food and beverage items in the People's Republic of China.
LKNC.Y
US$31.20
7D
-4.1%
1Y
-11.8%
Zscaler
Market Cap: US$20.9b
Operates as a cloud security company worldwide.
ZS
US$125.84
7D
-12.7%
1Y
-57.8%
Hesai Group
Market Cap: US$3.0b
Through with its subsidiaries, engages in the development, manufacture, and sale of three-dimensional light detection and ranging solutions (LiDAR) in Mainland China, Europe, North America, and internationally.
HSAI
US$18.44
7D
-14.9%
1Y
-4.8%
McEwen
Market Cap: US$1.1b
Engages in the exploration, development, production, and sale of gold and silver deposits in the United States, Canada, Mexico, and Argentina.
MUX
US$17.79
7D
-20.3%
1Y
91.9%
Intapp
Market Cap: US$1.9b
Through its subsidiary, Integration Appliance, Inc., provides AI-powered solutions in the United States, the United Kingdom, and internationally.
INTA
US$23.79
7D
-5.1%
1Y
-58.6%
Daqo New Energy
Market Cap: US$1.1b
Manufactures and sells polysilicon to photovoltaic product manufacturers in the People’s Republic of China.
DQ
US$14.39
7D
-14.3%
1Y
-2.4%
CG Oncology
Market Cap: US$4.8b
A late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States.
CGON
US$56.67
7D
2.1%
1Y
106.2%
Gossamer Bio
Market Cap: US$38.9m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States.
GOSS
US$0.16
7D
-20.1%
1Y
-87.2%
Arcutis Biotherapeutics
Market Cap: US$2.7b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$22.79
7D
9.6%
1Y
64.1%